BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11998515)

  • 1. [Results of using botulism toxin in the treatment of spasmodic dysphonia].
    Larrosa F; Idígora A; Aguilar F; Riera L; Martí MJ; Valls J
    Acta Otorrinolaringol Esp; 2002 Jan; 53(1):27-31. PubMed ID: 11998515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for the treatment of spasmodic dysphonia.
    Gibbs SR; Blitzer A
    Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for spasmodic dysphonia.
    Rodriquez AA
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
    Blitzer A; Brin MF; Stewart CF
    Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to botulinum toxin injections for spasmodic dysphonia.
    Smith ME; Ford CN
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies.
    Whurr R; Nye C; Lorch M
    Int J Lang Commun Disord; 1998; 33 Suppl():327-9. PubMed ID: 10343714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series.
    Blitzer A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():28-30. PubMed ID: 20590805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
    Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
    Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal electromyography in movement disorders: preliminary data.
    Kimaid PA; Quagliato EM; Crespo AN; Wolf A; Viana MA; Resende LA
    Arq Neuropsiquiatr; 2004 Sep; 62(3A):741-4. PubMed ID: 15334243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia.
    Meleca RJ; Hogikyan ND; Bastian RW
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):487-92. PubMed ID: 9374172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
    Brin MF; Blitzer A; Stewart C
    Adv Neurol; 1998; 78():237-52. PubMed ID: 9750921
    [No Abstract]   [Full Text] [Related]  

  • 16. Contemporary management of spasmodic dysphonia.
    Sulica L
    Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):543-8. PubMed ID: 15548915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Holzer SE; Ludlow CL
    Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.
    Meyer TK; Hu A; Hillel AD
    Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia.
    Damrose JF; Goldman SN; Groessl EJ; Orloff LA
    J Voice; 2004 Sep; 18(3):415-22. PubMed ID: 15331116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.